The Zimulti Acomplia Report
Now that a promising new prescription weight loss drug, rimonabant, it is today available in the U.K., Germany and 44 other countries, the launch of the most anticipated weight-loss Drug since Fen-phen is generating …
An announcement was made about Sanofi-Aventis.This refears to the launch of Acomplia (rimonabant), a new medication that treats abdominally obese persons which presents cardio metabolic risk cluster. …
Diet drug Acomplia (rimonabant) on Feb. 6th received a “‘favorable recommendation” for reimbursement by French health insurance companies and state social security plans for use limited to obese patients with type 2 diabetes insufficiently controlled by customary diabetes …
Obesity is becoming a problem going out of hand. It is time to curtail the problem by resorting to some means or the other. Obesity is considered a disease by the medical community. It has serious health risks like heart …
Information on Acomplia� (Rimonabant) (Possibly Zimulti�)
Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia� and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. …
What Is Rimonabant?
A single pill Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges. Named Rimonabant Acomplia the drug in one study helped people who were …